REDWOOD CITY, Calif. and HELSINKI – August 26, 2022 – MariaDB® Corporation today announced that the Defense Information Systems Agency (DISA), a U.S. Department of Defense (DOD) combat support agency, has approved the Security Technical Implementation Guide (STIG) for MariaDB Enterprise Server. To approve the STIG, DISA evaluated MariaDB Enterprise Server against hundreds of DOD security requirements. The STIG provides government … Continued
Database and database-as-a-service provider MariaDB has acquired a developer of advanced geospatial technology in a move that will make it easier for developers to incorporate geospatial data into their applications. MariaDB’s acquisition of CubeWerx comes as the volume of geospatial data is exploding, including location-based and imagery data generated by satellites and drones, location-aware devices, … Continued
REDWOOD CITY, Calif. and HELSINKI – March 29, 2022 – MariaDB® Corporation today announced that MariaDB has received recognition as “Database of the Year” in the LinuxQuestions.org Members Choice Awards poll. This marks the ninth consecutive year MariaDB has earned this recognition. Additionally, MariaDB has been named a finalist for Cloud Product of the Year … Continued
IRVINE, Calif., Sept. 13, 2021 /PRNewswire/ — AIVITA Biomedical, Inc., a private biotechnology company specializing in innovative cell therapies, today announced results from its Phase 2 clinical study testing AIVITA’s anti-SARS-CoV-2 Vaccine Enabling Kit, which allows any minimally-equipped facility to make personalized COVID-19 vaccines during the course of 2 patient visits one week apart. The Phase … Continued
Personalized cancer vaccine increases progression-free survival (PFS) by 50% IRVINE, Calif., June 8, 2021 /PRNewswire/ — AIVITA Biomedical, Inc., a private biotechnology company specializing in innovative stem cell applications, today announced data from its multi-center Phase 2 clinical trial of its personalized cancer vaccine, AV-GBM-1, in patients with newly diagnosed glioblastoma (GBM). The analysis focused on … Continued
RVINE, Calif.–(BUSINESS WIRE)–ClearFlow, Inc., a medical device company based in Irvine, California, has announced positive clinical trial results published in the peer-reviewed Journal of Cardiothoracic Surgery. The findings are reported by cardiac surgeons at the Montreal Heart Institute, in Montreal, Quebec, Canada in the article, “Active clearance vs conventional management of chest tubes after cardiac surgery: a … Continued
SkySQL on GCP powers FanGraphs’ comprehensive, data-driven projections for major and minor league baseball REDWOOD CITY, Calif. and HELSINKI – March 25, 2021 – MariaDB® Corporation today announced that popular baseball analysis site FanGraphs has drafted MariaDB SkySQL as its cloud database running on Google Cloud Platform (GCP) and SkyDBA for first-string, 24x7x365 teammate … Continued
REDWOOD CITY, Calif. and HELSINKI – March 10, 2021 – MariaDB® Corporation today announced that its cloud database MariaDB SkySQL has won the InfoWorld Technology of the Year Awards for 2021. The awards, which identify the best and most innovative products on the IT landscape, recognized SkySQL for its ability to deliver exceptional scale and … Continued
PRINCETON, N.J. & MORRISVILLE, N.C.–(BUSINESS WIRE)–Otsuka Pharmaceutical Development & Commercialization, Inc., and Spencer Health Solutions, Inc., today announced an agreement to jointly create a transformational patient experience using the spencer® smart hub, the world’s first at-home medication device that connects patients and their care teams through an easy-to-use, fully integrated platform. As part of the … Continued
Personalized cancer vaccine reduces risk of disease progression or death by 38% IRVINE, Calif., Nov. 17, 2020 /PRNewswire/ — AIVITA Biomedical, Inc., a private biotechnology company specializing in innovative stem cell applications, today announced data from its multi-center Phase 2 clinical trial of its personalized cancer vaccine, AV-GBM-1, in patients with newly diagnosed glioblastoma (GBM). The … Continued
